IVVD
IVVD
NASDAQ · Biotechnology

Invivyd Inc

$0.59
-0.05 (-7.51%)
As of Nov 7, 2:04 AM ET ·
Financial Highlights (FY 2026)
Revenue
87.85M
Net Income
-86,316,223
Gross Margin
93.0%
Profit Margin
-98.3%
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 93.0% 59.2% 59.2% 59.2%
Operating Margin -104.0% 3.3% 3.0% 2.9%
Profit Margin -98.3% 2.8% 1.9% 2.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 87.85M 178.19M 160.29M 142.80M
Gross Profit 81.69M 105.52M 94.92M 84.56M
Operating Income -91,350,481 5.95M 4.86M 4.16M
Net Income -86,316,223 4.92M 3.11M 2.81M
Gross Margin 93.0% 59.2% 59.2% 59.2%
Operating Margin -104.0% 3.3% 3.0% 2.9%
Profit Margin -98.3% 2.8% 1.9% 2.0%
Rev Growth — +11.2% +5.5% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 41.24M 37.88M 36.70M
Total Equity — 228.36M 219.75M 214.56M
D/E Ratio — 0.18 0.17 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -90,110,965 6.39M 5.91M 5.38M
Free Cash Flow — 2.75M 2.88M 2.77M